CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 9 of the 16 sources its claims cite were checked for support.

Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation

Open access
Eimer, William A, Vassar, Robert · 2013 · Molecular Neurodegeneration

Abstract

BACKGROUND: Although the mechanism of neuron loss in Alzheimer's disease (AD) is enigmatic, it is associated with cerebral accumulation of Aβ42. The 5XFAD mouse model of amyloid deposition expresses five familial AD (FAD) mutations that are additive in driving Aβ42 overproduction. 5XFAD mice exhibit intraneuronal Aβ42 accumulation at 1.5 months, amyloid deposition at 2 months, and memory deficits by 4 months of age. RESULTS: Here, we demonstrate by unbiased stereology that statistically significant neuron loss occurs by 9 months of age in 5XFAD mice. We validated two Aβ42-selective antibodies by immunostaining 5XFAD; BACE1-/- bigenic brain sections and then used these antibodies to show that intraneuronal Aβ42 and amyloid deposition develop in the same regions where neuron loss is observed in 5XFAD brain. In 5XFAD neuronal soma, intraneuronal Aβ42 accumulates in puncta that co-label for Transferrin receptor and LAMP-1, indicating endosomal and lysosomal localization, respectively. In addition, in young 5XFAD brains, we observed activated Caspase-3 in the soma and proximal dendrites of intraneuronal Aβ42-labeled neurons. In older 5XFAD brains, we found activated Caspase-3-positive punctate accumulations that co-localize with the neuronal marker class III β-tubulin, suggesting neuron loss by apoptosis. CONCLUSIONS: Together, our results indicate a temporal sequence of intraneuronal Aβ42 accumulation, Caspase-3 activation, and neuron loss that implies a potential apoptotic mechanism of neuron death in the 5XFAD mouse.

Overview

CoChat Summary

TL;DR

This study finds that in 5XFAD mice, intraneuronal Aβ42 appears before plaques and is followed by Caspase-3 activation and later neuron loss. The authors argue this supports a correlative apoptotic pathway for neuron death in this AD model.

Key findings

  • Unbiased stereology showed significant neuron loss in 5XFAD mice by 9 months of age; the authors estimate a ~25% loss of Layer 5 pyramidal neurons by 12 months.
  • Intraneuronal Aβ42 was detected as early as 1.5 months, before plaque appearance at about 2 months, and persisted as plaques increased with age.
  • Activated Caspase-3 was present in 5XFAD neurons by 1.5 months and became visible as punctate accumulations by 4 months; by 9 months, activated Caspase-3-positive puncta were found in the same regions as Aβ42 and neuron loss.
  • Aβ42 puncta partially co-localized with Transferrin receptor and LAMP1, suggesting localization to the endosomal-lysosomal system.

Methods

  • Used the 5XFAD transgenic mouse model and age-matched non-transgenic littermates; also included 5XFAD; BACE1−/− mice as negative controls for Aβ generation.
  • Measured neuron number by design-based unbiased stereology on cresyl-violet-stained parasagittal brain sections from female mice at 4, 6, 9, and 12 months.
  • Assessed Aβ42 and apoptosis-related markers by immunohistochemistry and confocal immunofluorescence microscopy, including co-staining with Aβ42, Cleaved Caspase-3, NeuN, class III β-tubulin, Transferrin receptor, and LAMP1.

Limitations

  • The authors explicitly note that the findings are correlative, so they do not prove that intraneuronal Aβ42 causes Caspase-3 activation or neuron loss.
  • They caution that interpretation requires care because the model is an “aggressive amyloid mouse model that overexpresses multiple FAD mutations.”
  • Evident from the text: Caspase-3 was not detected in whole-brain homogenates, suggesting region-specific signal may be missed by bulk analysis rather than excluded.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1750-1326-8-2

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 5XFAD mice exhibit neuron loss in Layer 5 cortex and subiculum. Parasagittal brain sections from representative 4- to 12-month-old non-transgenic littermate (A-E, K-N) and 5XFAD (F-J, O-R) female mice were stained with cresyl violet and micrographed to image Layer 5 cortex (A-J) and subiculum (K-R). Numbers indicate cortical layers and dashed lines identify borders between layers. Boxes in D and I outline the areas of increased magnification shown in E and J, respectively. The 5XFAD mouse exhibits visible loss of large pyramidal neurons at 9 months of age as evident by a decrease in stained neurons (H, Q, I, R, J). Increased magnification (J) shows a clear loss of large pyramidal neurons in Layer 5 of the 5XFAD mouse at 12 months compared to the non-transgenic (E). Scale bar in R = 280 μm for A-D, F-I; 110 μm for E, J; 80 μm for K-R.
Figure 1 5XFAD mice exhibit neuron loss in Layer 5 cortex and subiculum. Parasagittal brain sections from representative 4- to 12-month-old non-transgenic littermate (A-E, K-N) and 5XFAD (F-J, O-R) female mice were stained with cresyl violet and micrographed to image Layer 5 cortex (A-J) and subiculum (K-R). Numbers indicate cortical layers and dashed lines identify borders between layers. Boxes in D and I outline the areas of increased magnification shown in E and J, respectively. The 5XFAD mouse exhibits visible loss of large pyramidal neurons at 9 months of age as evident by a decrease in stained neurons (H, Q, I, R, J). Increased magnification (J) shows a clear loss of large pyramidal neurons in Layer 5 of the 5XFAD mouse at 12 months compared to the non-transgenic (E). Scale bar in R = 280 μm for A-D, F-I; 110 μm for E, J; 80 μm for K-R.CC BY · PubMed Central
Figure 2 Unbiased stereological analysis of 5XFAD mice reveals significant neuron loss in cortical Layer 5 at 9 and 12 months of age. Brains from age-matched non-transgenic littermate (non-Tg) and 5XFAD female mice were sectioned at 30 μm and stained with cresyl violet and imaged by light microscopy. Large pyramidal neurons were then counted in Layer 5 cortex using an optical fractionator. (A) Large pyramidal neuron numbers in non-transgenic and 5XFAD Layer 5 cortex from mice aged 4–12 months. At 9 and 12 months there is a statistically significant decrease in the number of large pyramidal neurons in 5XFAD compared to non-transgenic mice (* p<0.05, ** p<0.01; n = 5 mice per group). 5XFAD mice exhibited a progressive decrease in Layer 5 large pyramidal neuron number, which at 12 months represented a 24.8% loss compared to non-transgenic mice. (B) 6 month 5XFAD mice are separable into two subgroups: those with normal neuron counts (6Mo 5XFAD high) and those with low neuron counts indicating neuron loss (6Mo 5XFAD low). The 5XFAD low count group showed a statistically significant decrease in neuron number compared to age matched non-transgenic and 5XFAD normal count groups (* p<0.05, ** p<0.01, n = 5 non-Tg, n = 10 net 6 month 5XFAD).
Figure 2 Unbiased stereological analysis of 5XFAD mice reveals significant neuron loss in cortical Layer 5 at 9 and 12 months of age. Brains from age-matched non-transgenic littermate (non-Tg) and 5XFAD female mice were sectioned at 30 μm and stained with cresyl violet and imaged by light microscopy. Large pyramidal neurons were then counted in Layer 5 cortex using an optical fractionator. (A) Large pyramidal neuron numbers in non-transgenic and 5XFAD Layer 5 cortex from mice aged 4–12 months. At 9 and 12 months there is a statistically significant decrease in the number of large pyramidal neurons in 5XFAD compared to non-transgenic mice (* p<0.05, ** p<0.01; n = 5 mice per group). 5XFAD mice exhibited a progressive decrease in Layer 5 large pyramidal neuron number, which at 12 months represented a 24.8% loss compared to non-transgenic mice. (B) 6 month 5XFAD mice are separable into two subgroups: those with normal neuron counts (6Mo 5XFAD high) and those with low neuron counts indicating neuron loss (6Mo 5XFAD low). The 5XFAD low count group showed a statistically significant decrease in neuron number compared to age matched non-transgenic and 5XFAD normal count groups (* p<0.05, ** p<0.01, n = 5 non-Tg, n = 10 net 6 month 5XFAD).CC BY · PubMed Central
Figure 3 5XFAD mice exhibit intraneuronal Aβ42 prior to amyloid deposition and neuron loss. Parasagittal brain sections from 1.5 (G), 2 (H), 4 (A, I-T), 6 (B), 9 (C, E), and 12 (D, F) month mice were incubated with anti-Aβ42 C-terminal neo-epitope antibody, visualized by DAB staining, and micrographed. 5XFAD mice display progressive Aβ42-positive plaque deposition with age (A-D). In 5XFAD Layer 5 cortex, intraneuronal Aβ42 (arrows) is first observed at 1.5 months (G) and amyloid plaques at 2 months (H) of age. At high magnification, intraneuronal Aβ42 staining is confined within numerous small spherical puncta dispersed throughout the cytoplasm of the soma of large pyramidal neurons (K-O). The appearance of these Aβ42-positive puncta suggests membrane-bound intracellular compartments such as endosomes or lysosomes. Importantly, the absence of Aβ42 staining in 5XFAD; BACE1−/− neurons (E, P-T) demonstrates the selectivity of the antibody for Aβ42, and indicates that the antibody dos not cross-react with endogenous or transgenic APP under the conditions used. Aβ42 staining is also lacking in non-transgenic littermate (Non-Tg) sections (F, J). Scale bar = 400 μm (A-F), 40 μm (G-J), 9 μm (K-T).
Figure 3 5XFAD mice exhibit intraneuronal Aβ42 prior to amyloid deposition and neuron loss. Parasagittal brain sections from 1.5 (G), 2 (H), 4 (A, I-T), 6 (B), 9 (C, E), and 12 (D, F) month mice were incubated with anti-Aβ42 C-terminal neo-epitope antibody, visualized by DAB staining, and micrographed. 5XFAD mice display progressive Aβ42-positive plaque deposition with age (A-D). In 5XFAD Layer 5 cortex, intraneuronal Aβ42 (arrows) is first observed at 1.5 months (G) and amyloid plaques at 2 months (H) of age. At high magnification, intraneuronal Aβ42 staining is confined within numerous small spherical puncta dispersed throughout the cytoplasm of the soma of large pyramidal neurons (K-O). The appearance of these Aβ42-positive puncta suggests membrane-bound intracellular compartments such as endosomes or lysosomes. Importantly, the absence of Aβ42 staining in 5XFAD; BACE1−/− neurons (E, P-T) demonstrates the selectivity of the antibody for Aβ42, and indicates that the antibody dos not cross-react with endogenous or transgenic APP under the conditions used. Aβ42 staining is also lacking in non-transgenic littermate (Non-Tg) sections (F, J). Scale bar = 400 μm (A-F), 40 μm (G-J), 9 μm (K-T).CC BY · PubMed Central
Figure 4 Intraneuronal Aβ42 is partially localized within both endosomes and lysosomes in 5XFAD neurons. Parasagittal brain sections of 5XFAD (A, B, E-K) and 5XFAD; BACE1−/− (C, D) brains were co-stained with anti-Aβ42-selective antibody (A-K) and anti-APP (6E10: B, D; Karen [29]: E) or anti-Transferrin receptor (TfR) (F-H) or anti-LAMP1 (I-K) antibody, and DAPI for nuclei (A-K), and imaged by confocal microscopy. All mice were 4 months old, except mice used for LAMP1 immunostaining were 2 months (I-K). Label colors indicate fluorescence color. Note that APP staining appears widely distributed in the soma and cell surface (B, D, E), while Aβ42 labeling is confined to intraneuronal puncta in 5XFAD mice (A, B, E, F, I). Asterisk in E identifies Aβ42-positive plaque (red) above large pyramidal neuron that exhibits intraneuronal Aβ42 puncta (arrow). lntraneuronal Aβ42 signal is absent in 5XFAD; BACE1−/− neurons (C, D), again demonstrating the Aβ42-selectivity of the antibody. In 5XFAD neurons, intraneuronal Aβ42 co-localizes with Transferrin receptor in early endosomes (F-H) and with LAMP1 in late endosomes and early lysosomes (I-K), at least in part. Scale bar in D = 12μm (A, C); = 20 μm (B, D). Scale bar in K = 12 μm (E); = 20 μm (F-K).
Figure 4 Intraneuronal Aβ42 is partially localized within both endosomes and lysosomes in 5XFAD neurons. Parasagittal brain sections of 5XFAD (A, B, E-K) and 5XFAD; BACE1−/− (C, D) brains were co-stained with anti-Aβ42-selective antibody (A-K) and anti-APP (6E10: B, D; Karen [29]: E) or anti-Transferrin receptor (TfR) (F-H) or anti-LAMP1 (I-K) antibody, and DAPI for nuclei (A-K), and imaged by confocal microscopy. All mice were 4 months old, except mice used for LAMP1 immunostaining were 2 months (I-K). Label colors indicate fluorescence color. Note that APP staining appears widely distributed in the soma and cell surface (B, D, E), while Aβ42 labeling is confined to intraneuronal puncta in 5XFAD mice (A, B, E, F, I). Asterisk in E identifies Aβ42-positive plaque (red) above large pyramidal neuron that exhibits intraneuronal Aβ42 puncta (arrow). lntraneuronal Aβ42 signal is absent in 5XFAD; BACE1−/− neurons (C, D), again demonstrating the Aβ42-selectivity of the antibody. In 5XFAD neurons, intraneuronal Aβ42 co-localizes with Transferrin receptor in early endosomes (F-H) and with LAMP1 in late endosomes and early lysosomes (I-K), at least in part. Scale bar in D = 12μm (A, C); = 20 μm (B, D). Scale bar in K = 12 μm (E); = 20 μm (F-K).CC BY · PubMed Central
Figure 5 5XFAD mice exhibit Caspase-3 activation in Layer 5 cortex and subiculum. Parasagittal brain sections from representative 4 and 9 month old 5XFAD (A-D, I-L), non-transgenic littermate (Non-Tg; E, F, M, N), and 5XFAD; BACE1−/− (G, H, O, P) mice were incubated with an antibody against activated Caspase-3, visualized by DAB staining, and micrographed in Layer 5 cortex (A-H) and subiculum (I-P). The levels of activated Caspase-3 immunolabeling are significantly higher in the brains of both ages of 5XFAD mice compared to those of 5XFAD; BACE1−/− or non-transgenic mice. In addition, punctate aggregates of activated Caspase-3 are distributed throughout 5XFAD sections (black arrows, A-D, I-L), but are absent in 5XFAD; BACE1−/− or Non-Tg sections (E-H, M-P). Boxes in A, B, I, and J are enlarged in C, D, K, and L, respectively. Scale bar A, B, E-H, I, J, M-P = 80 μm; C, D, K, L = 40 μm.
Figure 5 5XFAD mice exhibit Caspase-3 activation in Layer 5 cortex and subiculum. Parasagittal brain sections from representative 4 and 9 month old 5XFAD (A-D, I-L), non-transgenic littermate (Non-Tg; E, F, M, N), and 5XFAD; BACE1−/− (G, H, O, P) mice were incubated with an antibody against activated Caspase-3, visualized by DAB staining, and micrographed in Layer 5 cortex (A-H) and subiculum (I-P). The levels of activated Caspase-3 immunolabeling are significantly higher in the brains of both ages of 5XFAD mice compared to those of 5XFAD; BACE1−/− or non-transgenic mice. In addition, punctate aggregates of activated Caspase-3 are distributed throughout 5XFAD sections (black arrows, A-D, I-L), but are absent in 5XFAD; BACE1−/− or Non-Tg sections (E-H, M-P). Boxes in A, B, I, and J are enlarged in C, D, K, and L, respectively. Scale bar A, B, E-H, I, J, M-P = 80 μm; C, D, K, L = 40 μm.CC BY · PubMed Central
Figure 6 5XFAD mice have elevated levels of activated Caspase-3 in neurons of Layer 5 cortex and subiculum. Parasagittal brain sections from 1.5, 4, and 9 month old 5XFAD mice were co-incubated with antibodies against activated Caspase-3 (green) and neuron-specific class III β-tubulin (red; A-F) or NeuN (red; G-L) and imaged by confocal microscopy. Sections were co-stained with DAPI to detect nuclei (blue). Co-immunolabeling with neuronal markers β-tubulin and NeuN demonstrate Caspase-3 activation in 5XFAD neurons. Note the presence of activated Caspase-3 labeling in proximal dendrites of large pyramidal neurons of Layer 5 cortex and subiculum at 1.5 and 4 months (A-D, G-J), The number of Caspase-3-positive proximal dendrites is reduced in 9 month old compared to younger 5XFAD mice, although Caspase-3 aggregates are more prevalent at older ages suggesting a progressive process (spherical green structures in E, F, K, L). Activated Caspase-3-positive aggregates become apparent at 4 months in Layer 5 cortex and later in subiculum, and likely represent neuronal apoptotic bodies. Arrows in F point to Caspase-3-positive aggregates that co-label with neuron-specific class III β-tubulin. Scale bar = 20 μm.
Figure 6 5XFAD mice have elevated levels of activated Caspase-3 in neurons of Layer 5 cortex and subiculum. Parasagittal brain sections from 1.5, 4, and 9 month old 5XFAD mice were co-incubated with antibodies against activated Caspase-3 (green) and neuron-specific class III β-tubulin (red; A-F) or NeuN (red; G-L) and imaged by confocal microscopy. Sections were co-stained with DAPI to detect nuclei (blue). Co-immunolabeling with neuronal markers β-tubulin and NeuN demonstrate Caspase-3 activation in 5XFAD neurons. Note the presence of activated Caspase-3 labeling in proximal dendrites of large pyramidal neurons of Layer 5 cortex and subiculum at 1.5 and 4 months (A-D, G-J), The number of Caspase-3-positive proximal dendrites is reduced in 9 month old compared to younger 5XFAD mice, although Caspase-3 aggregates are more prevalent at older ages suggesting a progressive process (spherical green structures in E, F, K, L). Activated Caspase-3-positive aggregates become apparent at 4 months in Layer 5 cortex and later in subiculum, and likely represent neuronal apoptotic bodies. Arrows in F point to Caspase-3-positive aggregates that co-label with neuron-specific class III β-tubulin. Scale bar = 20 μm.CC BY · PubMed Central
Figure 7 5XFAD mice display Caspase-3 activation in neurons with intraneuronal Aβ42. Parasagittal brain sections from 1.5 (A, E, C, G, K) and 4 month (B, D, F, H-J, L) 5XFAD (A-D, K, L), non-transgenic littermate (Non-Tg; E-H), and 5XFAD; BACE1−/− (I, J) mice were co-incubated with antibodies against activated Caspase-3 (green) and Aβ42 C-terminal neo-epitope (red) and imaged by confocal microscopy. Sections were co-stained with DAPI to detect nuclei (blue). Activated Caspase-3 is present in 5XFAD large pyramidal neurons of Layer 5 cortex (A, B, K, L) and subiculum (C, D) that also display intraneuronal Aβ42. At high magnification, activated Caspase-3 is distributed throughout in the soma and proximal dendrites of Aβ42-positive neurons (K, L). Neither activated Caspase-3 nor intraneuronal Aβ42 are present in neurons of Non-Tg (E-H) or 5XFAD; BACE1−/− (I, J) mice. Note presence of amyloid plaques (red) at 4 months in 5XFAD brain (B, D). Activated Caspase-3-positive ring-like structures (arrows, B, D) may represent neurons in the process of degeneration. Asterisk in A identifies background capillary staining. Scale bar A-J = 20 μm; K, L = 10 μm.
Figure 7 5XFAD mice display Caspase-3 activation in neurons with intraneuronal Aβ42. Parasagittal brain sections from 1.5 (A, E, C, G, K) and 4 month (B, D, F, H-J, L) 5XFAD (A-D, K, L), non-transgenic littermate (Non-Tg; E-H), and 5XFAD; BACE1−/− (I, J) mice were co-incubated with antibodies against activated Caspase-3 (green) and Aβ42 C-terminal neo-epitope (red) and imaged by confocal microscopy. Sections were co-stained with DAPI to detect nuclei (blue). Activated Caspase-3 is present in 5XFAD large pyramidal neurons of Layer 5 cortex (A, B, K, L) and subiculum (C, D) that also display intraneuronal Aβ42. At high magnification, activated Caspase-3 is distributed throughout in the soma and proximal dendrites of Aβ42-positive neurons (K, L). Neither activated Caspase-3 nor intraneuronal Aβ42 are present in neurons of Non-Tg (E-H) or 5XFAD; BACE1−/− (I, J) mice. Note presence of amyloid plaques (red) at 4 months in 5XFAD brain (B, D). Activated Caspase-3-positive ring-like structures (arrows, B, D) may represent neurons in the process of degeneration. Asterisk in A identifies background capillary staining. Scale bar A-J = 20 μm; K, L = 10 μm.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 3 Not valid · 2 Not checked · 28 Own results and interpretations

19 more claims

Create a free account to see all 35 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 2
  • It may state two separate claims as one. 10
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

10 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 50 references

Cited by

See all 425

Metadata

Authors
Eimer, W. A., & Vassar, R.
Affiliations
Northwestern University (US)
Corresponding author
Vassar, Robert
Venue
Molecular Neurodegeneration
Published
2013
Volume
8
Issue
1
Pages
2
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2011982570
Cited by
425
References
50
Citations by year
2026: 40 · 2025: 66 · 2024: 43 · 2023: 43 · 2022: 42 · 2021: 42 · 2020: 37 · 2019: 25 · 2018: 20 · 2017: 21 · 2016: 13 · 2015: 17 · 2014: 13 · 2013: 3
FWCI
10.65
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • MetLife Foundation
  • Alzheimer's Association
  • Northwestern University (CA060553, NCI CCSG P30 CA060553, P30CA060553)
  • National Institutes of Health (CCSG P30, CA-060553, AG022560, NCI CCSG P30 CA060553, CCSG P30 CA060553)
  • National Institute on Aging (R01AG022560)
  • National Cancer Institute (NCI CCSG P30 CA060553, CA 060553, CCSGP30CA060553, P30CA060553)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, neuronal loss, 5xFAD mice, amyloid-beta 42, caspase-3 activation, neuronal apoptosis, stereology, transferrin receptor, LAMP1, lysosomal localization, amyloid deposition, familial Alzheimer's disease mutations, BACE1
MeSH terms
Alzheimer Disease, Animals, Disease Models, Animal, Mice, Transgenic, Neurons, Peptide Fragments, Amyloid beta-Peptides, Mice, Caspase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation. https://app.cochat.ai/papers/10.1186/1750-1326-8-2
The paper
Eimer, W. A., & Vassar, R. (2013). Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation. Molecular Neurodegeneration. https://doi.org/10.1186/1750-1326-8-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.